Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV.
D000230:Adenocarcinoma / Q000473:pathology / Q000532:radiotherapy*; D000368:Aged; D000704:Analysis of Variance; D019583:Dose Fractionation, Radiation; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011471:Prostatic Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D011832:Radiation Injuries / Q000473:pathology; D020266:Radiotherapy, Conformal / Q000009:adverse effects*; D013997:Time Factors